Sertoli -Leydig Cell Tumor of Ovary-
A Diagnostic Dilemma
Published: March 1, 2014 | DOI: https://doi.org/10.7860/JCDR/2014/.4099
Rohini Dhanya C.S., Somanath Padhi, Renu G’Boy Varg hese
1. Tutor, Department of Pathology, Dr. B.R. Ambedkar Medical College and Hospital, Bangalore, India, Ex-Senior Resident, Department of Pathology, Pondicherry
Institute of Medical Sciences, Ganapathychettykulam, Kalapet, Puducherry, India.
2. Assistant Professor, Department of Pathology, Pondicherry Institute of Medical Sciences, Ganapathychettykulam, Kalapet, Puducherry, India.
3. Professor and HOD, Department of Pathology, Pondicherry Institute of Medical Sciences, Ganapathychettykulam, Kalapet, Puducherry, India.
Correspondence
Dr. Rohini Dhanya C.S.,
# 402, Rathna Nest, 1st Cross, Obamma Lane, S.R. Layout, Wind Tunnel Road,
Murugeshpalya, Bangalore – 560017, India.
Phone: +91-9880040734, E-mail: dr.rohinidhanya@gmail.com
Sertoli Leydig Cell Tumours (SLCTs) are rare, unilateral, sex cord stromal tumours of ovary, which constitute less than 1% of all the ovarian neoplasms. These tumours can be functionally diverse and they may have heterologous elements. We aim to report a case of a 25-year- old woman who presented with suprapubic pain of 5 days duration, a unilateral adnexal mass, hypertestosteronism without virilization. Intraoperative frozen section of the unilateral salpingo-oophorectomy specimen was suggestive of granulosa cell tumour. Histopathological examination, supplemented with alpha-inhibin immunohistochemistry, was diagnostic of Meyer’s type II SLCT. Clinical presentation, pathology and the diagnostic pitfalls in the present case have been presented with a brief review of literature.
[
FULL TEXT ] | [ PDF]